Literature DB >> 25510219

Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy.

Q-F Xiong, Y-D Zhong, Z-L Hu, Y-F Yang.   

Abstract

We have reported a case of occult hepatitis B virus infection (OBI) associated membranous nephropathy (MN) with complete remission under an ongoing 3.5-year entecavir monotherapy. A 59-year-old man with a 3-year history of liver cirrhosis was introduced to our department because of oliguria, proteinuria and microscopic haematuria. He, with negative serum HBV surface antigen, was not detected HBV DNA in his serum. Renal biopsy was performed and was compatible with a diagnosis of hepatitis B virus-related membranous nephropathy (HBV-MN). The patient was prescribed diuretics and intravenous albumin, and his ascites and oedema remitted gradually. At the same time, entecavir 0.5 mg per day was started. Entecavir treatment was continuing for 3.5 years and finally resulted in complete remission of proteinuria. This suggests that entecavir monotherapy may induce and maintain complete remission of MN associated with OBI.

Entities:  

Keywords:  Entecavir,; Membranous nephropathy,; Nephrotic syndrome; Occult hepatitis B virus infection,

Mesh:

Substances:

Year:  2014        PMID: 25510219     DOI: 10.1179/2295333714Y.0000000108

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  1 in total

1.  Frequency of OBI among Patients with Autoimmune Hepatitis.

Authors:  Golnaz Hayat Davoudi; Manoochehr Makvandi; Ali Teimoori; Alireza Samarbafzade; Somayeh Biparva Haghighi; Akbar Bavi; Pezhman Alavinejad; Hossein Keyvani
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.